XML 28 R19.htm IDEA: XBRL DOCUMENT v3.22.2
Earnings Per Common Share
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Earnings Per Common Share

NOTE 11 – EARNINGS PER COMMON SHARE

The factors used in the earnings per common share computation follow:

 

 

 

For the Three Months
Ended June 30,

 

 

For the Six Months
Ended June 30,

 

 

 

2022

 

 

2021(1)

 

 

2022

 

 

2021(1)

 

Earnings per share

 

 

 

 

 

 

 

 

 

 

 

 

Net Income

 

$

1,312

 

 

$

847

 

 

$

2,322

 

 

$

1,632

 

Less: Distributed earning allocated to participating
   securities

 

 

 

 

 

 

 

 

 

 

 

 

Less: Earnings allocated to participating securities

 

 

(10

)

 

 

 

 

 

(35

)

 

 

(26

)

Net earnings allocated to common stock

 

 

1,302

 

 

 

847

 

 

 

2,287

 

 

 

1,606

 

Weighted common shares outstanding
   including participating securities

 

 

7,405,893

 

 

 

6,734,092

 

 

 

7,405,893

 

 

 

6,733,999

 

Less: Participating securities

 

 

(181,811

)

 

 

(227,272

)

 

 

(181,811

)

 

 

(227,272

)

Less: Average unearned ESOP shares

 

 

(352,079

)

 

 

(16,060

)

 

 

(353,911

)

 

 

(16,060

)

Weighted average shares

 

 

6,872,003

 

 

 

6,490,760

 

 

 

6,870,171

 

 

 

6,490,667

 

Basic earnings per share

 

$

0.19

 

 

$

0.13

 

 

$

0.33

 

 

$

0.25

 

Dilutive

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings allocated to common stock

 

 

1,302

 

 

 

847

 

 

 

2,287

 

 

 

1,606

 

Weighted average shares

 

 

6,872,003

 

 

 

6,490,760

 

 

 

6,870,171

 

 

 

6,490,667

 

Add: dilutive effects of assumed exercises of stock
   options

 

 

93,129

 

 

 

293,901

 

 

 

86,568

 

 

 

294,423

 

Average shares and dilutive potential common shares

 

 

6,965,132

 

 

 

6,784,661

 

 

 

6,956,739

 

 

 

6,785,090

 

Dilutive earnings per share

 

$

0.19

 

 

$

0.12

 

 

$

0.33

 

 

$

0.24

 

 

(1) Share amounts related to the periods prior to the July 15, 2021 closing of the conversion offering have been restated to give retroactive recognition to the 2.8409 exchange ratio applied in the conversion offering (see Note 1).

 

There were no antidilutive shares for the three and six months ended June 30, 2022 and 2021.